📇 Rhumatologue · PARIS CEDEX 18 · (75) · Hospitalier
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
Expérience confirmée
16 ans d'exercice en rhumatologie — recul clinique solide
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
16ans d'exercice (thèse 2010)
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
69
69 articles ont été cités au moins 69fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
22 399
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
234
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
155
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Université Claude Bernard Lyon 1 · Inserm · Université Paris Cité
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Immune dysregulation through longitudinal lymphocyte trajectories and their clinical determinants in hospitalized COVID-19 patients
2026ArticleIntensive Care Medicine Experimental
Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock
2026ArticleJAMA Cardiology
Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial
2025ArticleThe Lancet Respiratory Medicine
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial
2025ArticleScientific Reports
Clinical phenotypes and outcomes associated with respiratory syncytial virus infection in critically ill patients : a retrospective multicentre cohort study in Great Paris area hospitals, 2017-2023
2025ArticleJournal of Infectious Diseases
Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials
2024ArticleBMC Cancer
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods
2024ArticleScientific Reports
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
2024ArticleHeliyon
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP NUP SITE BICHAT C BERNARD
46 R HENRI HUCHARD, 75877 PARIS CEDEX 18
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Intensive & critical care nursing · 2022
Proceedings of the National Academy of Sciences of the United States of America · 2022
Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It is important to estimate their quantitative impact on COVID-19 mortality upon SARS-CoV-2 infection, by age and sex, as both the prevalence of these autoantibodies and the risk of COVID-19 death increase with age and are higher in men. Using an unvaccinated sample of 1,261 deceased patients and 34,159 individuals from the general population, we found that autoantibodies against type I IFNs strongly increased the SARS-CoV-2 infection fatality rate at all ages, in both men and women. Autoantibodies against type I IFNs are strong and common predictors of life-threatening COVID-19. Testing for these autoantibodies should be considered in the general population.
Critical care (London, England) · 2021
AbstractSepsis is a common consequence of infection, associated with a mortality rate > 25%. Although community-acquired sepsis is more common, hospital-acquired infection is more lethal. The most common site of infection is the lung, followed by abdominal infection, catheter-associated blood steam infection and urinary tract infection. Gram-negative sepsis is more common than gram-positive infection, but sepsis can also be due to fungal and viral pathogens. To reduce mortality, it is necessary to give immediate, empiric, broad-spectrum therapy to those with severe sepsis and/or shock, but this approach can drive antimicrobial overuse and resistance and should be accompanied by a commitment to de-escalation and antimicrobial stewardship. Biomarkers such a procalcitonin can provide decision support for antibiotic use, and may identify patients with a low likelihood of infection, and in some settings, can guide duration of antibiotic therapy. Sepsis can involve drug-resistant pathogens, and this often necessitates consideration of newer antimicrobial agents.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026 · Journal Article
Nardy T, Rondinaud E, Dessajan J, Lo S, et al.
Annals of intensive care · 2025 · Journal Article
Vaconsin LM, Bonnal C, Argy N, Dessajan J, et al.
Annals of intensive care · 2025 · Journal Article
Do Rego H, Dessajan J, Le Hingrat Q, Lefevre LA, et al.
Expert opinion on drug metabolism & toxicology · 2025 · Journal Article
Rabault C, Bailly S, Thy M, de Montmollin E, et al.
Critical care (London, England) · 2025 · Journal Article
Dessajan J, Thy M, Doman M, Stern J, et al.
Journal of intensive care · 2025 · Journal Article
Thy M, Sonneville R, Ruckly S, Mourvillier B, et al.
Critical care explorations · 2025 · Journal Article
Ortuno S, Bachelet D, Varnet O, Tridon C, et al.
Critical care explorations · 2024 · Journal Article
Tridon C, Bachelet D, El Baied M, Eloy P, et al.
The Journal of infection · 2024 · Journal Article
Mokrani D, Le Hingrat Q, Thy M, Choquet C, et al.
Annals of intensive care · 2024 · Journal Article
Thy M, Dupuis C, Mageau A, Mourvillier B, et al.
Current opinion in critical care · 2023 · Review
Thy M, de Montmollin E, Bouadma L, Timsit JF, et al.
Frontiers in medicine · 2023 · Journal Article
Doman M, Thy M, Dessajan J, Dlela M, et al.
Journal of clinical immunology · 2023 · Published Erratum
Hocini H, Wiedemann A, Blengio F, Lefebvre C, et al.
Journal of clinical immunology · 2023 · Journal Article
Hocini H, Wiedemann A, Blengio F, Lefebvre C, et al.
Annals of intensive care · 2022 · Journal Article
Rambaud T, de Montmollin E, Jaquet P, Gaudemer A, et al.
Critical care explorations · 2022 · Journal Article
Abid S, Papin G, Vellieux G, de Montmollin E, et al.
Critical care (London, England) · 2022 · Journal Article
Patrier J, Villageois-Tran K, Szychowiak P, Ruckly S, et al.
Antibiotics (Basel, Switzerland) · 2022 · Journal Article
de Montmollin E, Peoc'h K, Marzouk M, Ruckly S, et al.
Critical care medicine · 2022 · Journal Article
Jaquet P, Legouy C, Le Fevre L, Grinea A, et al.
Intensive & critical care nursing · 2022 · Journal Article
Blot S, Ruppé E, Harbarth S, Asehnoune K, et al.
Proceedings of the National Academy of Sciences of the United States of America · 2022 · Journal Article
Manry J, Bastard P, Gervais A, Le Voyer T, et al.
Research square · 2022 · Preprint
Manry J, Bastard P, Gervais A, Le Voyer T, et al.
Journal of medical case reports · 2022 · Case Reports
Goletto T, Decaux S, Bunel V, Weisenburger G, et al.
Critical care (London, England) · 2021 · Journal Article
Meyer A, Buetti N, Houhou-Fidouh N, Patrier J, et al.
Journal of clinical virology plus · 2021 · Journal Article
Crescenzo-Chaigne B, Behillil S, Enouf V, Escriou N, et al.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021 · Published Erratum
Le Hingrat Q, Visseaux B, Laouenan C, Tubiana S, et al.
Critical care (London, England) · 2021 · Journal Article
Niederman MS, Baron RM, Bouadma L, Calandra T, et al.
iScience · 2021 · Journal Article
Lévy Y, Wiedemann A, Hejblum BP, Durand M, et al.
Annals of intensive care · 2021 · Published Erratum
Lemiale V, Dumas G, Demoule A, Pène F, et al.
Scientific reports · 2021 · Journal Article
Crawford C, Vanoli E, Decorde B, Lancelot M, et al.
The Lancet regional health. Europe · 2021 · Journal Article
Lefrancq N, Paireau J, Hozé N, Courtejoie N, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · Journal Article
Buetti N, Patrier J, Le Hingrat Q, Loiodice A, et al.
Annals of intensive care · 2021 · Journal Article
Touchard C, Cartailler J, Vellieux G, de Montmollin E, et al.
JAMA · 2026 · Comparative Study
Sonneville R, Couffignal C, Sigaud F, Thy M, et al.
The Lancet. Respiratory medicine · 2025 · Journal Article
Lemiale V, Resche-Rigon M, Zerbib Y, Mokart D, et al.
BMC cancer · 2024 · Journal Article
Gregoriano C, Wirz Y, Heinsalo A, Annane D, et al.
Journal of medical virology · 2023 · Journal Article
Gault N, Bachelet D, Laouénan C, Borie R, et al.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2023 · Journal Article
Stern J, Dupuis C, Kpeglo H, Reuter J, et al.
Annals of intensive care · 2022 · Journal Article
Egea A, Dupuis C, de Montmollin E, Wicky PH, et al.
BMC cancer · 2024 · Journal Article
Gregoriano C, Wirz Y, Heinsalo A, Annane D, et al.
Age and ageing · 2021 · Journal Article
Heilmann E, Gregoriano C, Annane D, Reinhart K, et al.
Scientific reports · 2026 · Published Erratum
Piljan M, Celier A, Vellieux G, Pecot I, et al.
Scientific reports · 2025 · Journal Article
Piljan M, Celier A, Vellieux G, Pecot I, et al.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023 · Journal Article
Dumont M, Guilhou T, Gerin M, Frémont-Goudot G, et al.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021 · Clinical Trial, Phase III
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, et al.
Intensive care medicine · 2025 · Journal Article
Gaillet A, Luyt CE, Timsit JF, Asehnoune K, et al.
Additional file 5: Figure S2. of Severe varicella-zoster virus pneumonia: a multicenter cohort study
Influence of age on mortality in patients with VZV pneumonia. (TIFF 675 kb)
The ICU-Diary study: prospective, multicenter comparative study of the impact of an ICU diary on the wellbeing of patients and families in French ICUs
Abstract Background Post-intensive care syndrome includes the multiple consequences of an intensive care unit (ICU) stay for patients and families. It has become a new challenge for intensivists. Prevention programs have
Additional file 2: Figure S1. of Severe varicella-zoster virus pneumonia: a multicenter cohort study
Seasonal distribution of VZV pneumonia from 1996 to 2015. (TIFF 731 kb)
Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation
Abstract Background Infectious complications are a major cause of morbidity and mortality after heart transplantation (HT). However, the epidemiology and outcomes of these infections in the recent population of adult hea
Changes in the clinical presentation and outcomes of patients treated for severe malaria in a referral French university intensive care unit from 2004 to 2017
Abstract Background In France, the incidence of severe imported malaria cases increased since early 2000. Artesunate was available (temporarily use authorization) since mid-2011 in France and commonly used for severe mal
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
BMJ open · 2024 · Clinical Trial Protocol
Sonneville R, Couffignal C, Sigaud F, Godard V, et al.
Annals of intensive care · 2023 · Journal Article
Chevret S, Bouadma L, Dupuis C, Burdet C, et al.
Annals of intensive care · 2023 · Published Erratum
Chevret S, Bouadma L, Dupuis C, Burdet C, et al.
Critical care (London, England) · 2022 · Randomized Controlled Trial
Soum E, Timsit JF, Ruckly S, Gruson D, et al.
JAMA internal medicine · 2022 · Journal Article
Bouadma L, Mekontso-Dessap A, Burdet C, Merdji H, et al.
Age and ageing · 2021 · Journal Article
Heilmann E, Gregoriano C, Annane D, Reinhart K, et al.